Literature DB >> 2211029

Changes in aqueous outflow after in vitro neodymium: yttrium aluminum garnet laser cyclophotocoagulation.

H D Schubert1, A Agarwala, V Arbizo.   

Abstract

To examine the possible role of transscleral outflow routes, enucleated human and porcine eyes underwent noncontact neodymium:yttrium aluminum garnet (Nd:YAG) laser cyclophotocoagulation 3 mm posterior to the limbus. Pars plana lesions were verified histologically. The eyes were perfused with saline solution at 50 mm Hg perfusion pressure, placing the tip of the needle into the hyaloid orbicular space. The outflow facility was 0.072 microliter/min/mm Hg in paired controls and 0.105 microliter/min/mm Hg in human lasered eyes, a difference of 31%. In porcine eyes the difference was 43%. Since concepts of aqueous production, impaired circulation, and inflammation do not apply to enucleated eyes, the increase may be related to pars plana transscleral flow facilitated by disruption of the neuroepithelial barrier.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211029

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Endoscopic and transscleral cyclophotocoagulation.

Authors:  P A Bloom; S Dharmaraj
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

2.  Postvitrectomy hypotonia: the role of the vitreous and retinochoroidal lesions.

Authors:  H D Schubert; K Kuang; J Fischbarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

Review 3.  Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options.

Authors:  Anna I Dastiridou; Andreas Katsanos; Philippe Denis; Brian A Francis; Dimitrios G Mikropoulos; Miguel A Teus; Anastasios-Georgios Konstas
Journal:  Adv Ther       Date:  2018-11-17       Impact factor: 3.845

Review 4.  Lasers in glaucoma.

Authors:  Harsh Kumar; Tarannum Mansoori; Gazella B Warjri; Bindu I Somarajan; Suman Bandil; Viney Gupta
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.